COMPLICANZE DEI SISTEMI INFUSIVI TOTALMENTE IMPIANTABILI NEI PAZIENTI NEOPLASTICI E CON AIDS

Translated title of the contribution: Complications of subcutaneous implanted venous access systems in neoplastic and AIDS patients

T. Cebrelli, V. Jemos, A. Ferrari, P. Gobbi, L. Minoli, L. Vai, R. Nucera, P. Dionigi

Research output: Contribution to journalArticle

Abstract

Totally implantable infusion systems (TIIS) were inserted in 5 patients with short bowel syndrome (group 1, 61 ± 11 y) for homeparenteral nutrition, in 11 patients with AIDS (group 2, 35 ± 14 y) for long term antiviral therapy and parenteral nutrition and in 15 patients with lymphoma or multiple myeloma (group 3, 56 ± 15 y) for cyclic chemiotherapy. Total duration of venous acces was 2110 days in group 1 (mean duration 422 days/pt, range 20-1257 days/pt), 1254 days in group 2 (mean 114 days/pt; range 43-262 days/pt) and 6230 days in group 3 (mean 415 days/pt,: range 62-1280 days/pt). In group 2, four patients (36%) developed catheter related sepsis (CRS) (0.32 per 100 catheter days), one patient occlusion of the chamber and all TIIS were explanted: The group 3 developed: one migration of the chamber (6%) explanted, one occlusion (6%) removed, and three CRS (17%; 0.05 per 100 catheter days); only one TIIS was removed. Among group 1 no patient developed complications. These results demonstrate that totally implantable infusion systems can be utilized for prolonged periods of time in neoplastic and AIDS patients if the expectance of life is acceptable.

Translated title of the contributionComplications of subcutaneous implanted venous access systems in neoplastic and AIDS patients
Original languageItalian
Pages (from-to)83-89
Number of pages7
JournalRivista Italiana di Nutrizione Parenterale ed Enterale
Volume12
Issue number2
Publication statusPublished - 1994

ASJC Scopus subject areas

  • Food Science
  • Anatomy
  • Critical Care and Intensive Care Medicine
  • Nutrition and Dietetics

Fingerprint Dive into the research topics of 'Complications of subcutaneous implanted venous access systems in neoplastic and AIDS patients'. Together they form a unique fingerprint.

  • Cite this